Loading clinical trials...
Loading clinical trials...
This project seeks to develop a quantitative imaging biomarker for evaluating and monitoring treatment response in ovarian cancer metastases and assess its potential in monitoring treatment response. ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Institute of Cancer Research, United Kingdom
Collaborators
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT06964009 · Ovarian Cancer, Ovarian Carcinoma, and more
NCT00539162 · Ovarian Cancer
NCT05005403 · Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, and more
Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire
Queen Elizabeth Hospital
Newcastle, Gateshead
Mount Vernon Cancer Centre
Northwood, Middlesex
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions